CA2383570A1 - Pourable liquid vehicles - Google Patents
Pourable liquid vehicles Download PDFInfo
- Publication number
- CA2383570A1 CA2383570A1 CA002383570A CA2383570A CA2383570A1 CA 2383570 A1 CA2383570 A1 CA 2383570A1 CA 002383570 A CA002383570 A CA 002383570A CA 2383570 A CA2383570 A CA 2383570A CA 2383570 A1 CA2383570 A1 CA 2383570A1
- Authority
- CA
- Canada
- Prior art keywords
- liquid vehicles
- pourable liquid
- compositions
- substances
- materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Abstract
The present invention covers pourable liquid vehicles that can be combined with compositions, materials and substances.
Among the benefits of such pourable liquid vehicles the compositions are retained on the moistened surface for a period of time sufficient to allow compositions, materials and substances to act on said surface, resisting erosion or run-off from additional moisture being applied. Such pourable liquid vehicles have a number of utilities including but not limited to cleaning and treating surfaces of objects as well as biological or living organisms, including living creatures.
Among the benefits of such pourable liquid vehicles the compositions are retained on the moistened surface for a period of time sufficient to allow compositions, materials and substances to act on said surface, resisting erosion or run-off from additional moisture being applied. Such pourable liquid vehicles have a number of utilities including but not limited to cleaning and treating surfaces of objects as well as biological or living organisms, including living creatures.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15326099P | 1999-09-11 | 1999-09-11 | |
US60/153,260 | 1999-09-11 | ||
PCT/US2000/024732 WO2001019329A2 (en) | 1999-09-11 | 2000-09-11 | Polyoxyalkylene copolymers containing pourable liquid vehicles |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2383570A1 true CA2383570A1 (en) | 2001-03-22 |
CA2383570C CA2383570C (en) | 2008-08-12 |
Family
ID=22546438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002383570A Expired - Fee Related CA2383570C (en) | 1999-09-11 | 2000-09-11 | Pourable liquid vehicles |
Country Status (12)
Country | Link |
---|---|
US (1) | US6503955B1 (en) |
EP (1) | EP1212091B1 (en) |
JP (1) | JP2003509350A (en) |
CN (1) | CN1373674A (en) |
AT (1) | ATE355082T1 (en) |
AU (1) | AU770516B2 (en) |
CA (1) | CA2383570C (en) |
DE (1) | DE60033671T2 (en) |
ES (1) | ES2282134T3 (en) |
MX (1) | MXPA02002607A (en) |
TR (1) | TR200200616T2 (en) |
WO (1) | WO2001019329A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY26380A1 (en) | 1999-10-08 | 2001-04-30 | Smithkline Beecham Corp | FAB I INHIBITORS |
CN1215837C (en) * | 2000-08-25 | 2005-08-24 | 兴和株式会社 | Ibuprofen solutions for capsule-filling and capsule preparations |
BRPI0115531B1 (en) * | 2000-11-22 | 2015-10-13 | Rxkinetix Inc | therapeutic composition useful for treating mucositis at a mucosal site as a side effect of cancer therapy |
US7049310B2 (en) | 2001-04-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
FR2838349B1 (en) * | 2002-04-15 | 2004-06-25 | Laurence Paris | LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME |
DK1575951T3 (en) | 2002-12-06 | 2014-09-15 | Debiopharm Int Sa | HETEROCYCLIC COMPOUNDS, METHODS OF PRODUCING THEREOF AND THEIR USE IN THERAPY |
US20060140985A1 (en) * | 2003-01-10 | 2006-06-29 | Zhong Zhang | Lansoprazole formulations and related processes and methods |
WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
JP2006008696A (en) * | 2003-03-20 | 2006-01-12 | Mitsubishi Pharma Corp | Pharmaceutical preparation containing arginine amides |
US7811601B2 (en) * | 2003-04-03 | 2010-10-12 | Seed Co., Ltd. | Ophthalmic lenses capable of sustained drug release and preservative solutions therefor |
US20050118261A1 (en) * | 2003-06-12 | 2005-06-02 | Oien Hal J. | Compositions and methods of administering doxepin to mucosal tissue |
WO2005060933A1 (en) * | 2003-12-11 | 2005-07-07 | Alcon, Inc. | Ophthalmic compositions containing a polysaccharide/borate gelling system |
PT1828167E (en) * | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Acrylamide derivatives as antibiotic agents |
CN1311873C (en) * | 2004-06-30 | 2007-04-25 | 上海复康医药科技发展有限公司 | Temperature sensitive gel formulation for in situ vagina uses |
US7947508B2 (en) * | 2004-11-30 | 2011-05-24 | Align Technology, Inc. | Systems and methods for intra-oral diagnosis |
US20060115782A1 (en) * | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for coating a dental appliance |
US7766658B2 (en) * | 2004-11-30 | 2010-08-03 | Align Technology, Inc. | Systems and methods for intra-oral diagnosis |
US20060115785A1 (en) * | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for intra-oral drug delivery |
WO2006091719A2 (en) * | 2005-02-23 | 2006-08-31 | Sontra Medical Corporation | Compositions and methods enhancing transdermal delivery of drugs and biologics |
EP1965787B1 (en) * | 2005-11-30 | 2013-04-10 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
EP1973902A2 (en) * | 2005-12-05 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
US20070196329A1 (en) * | 2006-01-20 | 2007-08-23 | Erning Xia | Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses |
WO2007104173A2 (en) * | 2006-03-10 | 2007-09-20 | Laboswiss Ag | Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
US8318720B2 (en) * | 2006-07-20 | 2012-11-27 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as Fab I inhibitors |
EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | Salts, prodrugs and polymorphs of fab i inhibitors |
WO2012135422A2 (en) * | 2011-04-01 | 2012-10-04 | University Of Florida Research Foundation, Inc. | Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
ITFI20110241A1 (en) * | 2011-11-03 | 2013-05-04 | Lo Li Pharma Srl | FORMULATIONS TO IMPROVE THE PROBABILITY OF FECONDATION AND THE NUMBER OF PREGNANCIES |
CN104684922B (en) | 2012-06-19 | 2016-10-26 | 德彪药业国际股份公司 | (E) prodrug derivant of-N-methyl-N-((3-methyl benzofuran-2-base) methyl)-3-(7-oxo-5,6,7,8-tetrahydrochysene-1,8-naphthyridines-3-base) acrylamide |
UY36570A (en) * | 2015-02-26 | 2016-10-31 | Merial Inc | INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME |
LT3419628T (en) | 2016-02-26 | 2021-01-25 | Debiopharm International Sa | Medicament for treatment of diabetic foot infections |
DK3576718T3 (en) | 2017-02-01 | 2021-08-23 | Johnson & Johnson Consumer Inc | PASTIL |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4100271A (en) | 1976-02-26 | 1978-07-11 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4188373A (en) | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4478822A (en) | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474752A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4511563A (en) | 1983-07-15 | 1985-04-16 | Basf Wyandotte Corporation | Clear analgesic gels with reduced tackiness |
EP0211601A3 (en) | 1985-07-30 | 1988-01-13 | International Minerals And Chemical Corporation | Stabilization of growth promoting hormones |
DE3532562A1 (en) * | 1985-09-12 | 1987-03-12 | Dolorgiet Gmbh & Co Kg | TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
US5030448A (en) | 1986-05-15 | 1991-07-09 | Emory University | Method of delivering drugs to damaged or diseased tissue |
US4810503A (en) | 1987-03-31 | 1989-03-07 | Basf Corporation | Polymers which form gels at low concentrations in water |
US4911926A (en) | 1988-11-16 | 1990-03-27 | Mediventures Inc. | Method and composition for reducing postsurgical adhesions |
US5681576A (en) * | 1988-11-16 | 1997-10-28 | Mdv Technologies, Inc. | Method and composition for post surgical adhesion reduction |
US5135751A (en) | 1988-11-16 | 1992-08-04 | Mediventures Incorporated | Composition for reducing postsurgical adhesions |
US5256396A (en) | 1990-01-24 | 1993-10-26 | Colgate-Palmolive Company | Topical composition |
US5306501A (en) | 1990-05-01 | 1994-04-26 | Mediventures, Inc. | Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
US5300295A (en) | 1990-05-01 | 1994-04-05 | Mediventures, Inc. | Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
US5298260A (en) | 1990-05-01 | 1994-03-29 | Mediventures, Inc. | Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality |
US5292516A (en) | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
US5071644A (en) | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
US5143731A (en) | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
US5346703A (en) | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
CN1106259A (en) | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition |
WO1997021441A1 (en) | 1995-12-11 | 1997-06-19 | Mdv Technologies, Inc. | Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers |
-
2000
- 2000-09-11 JP JP2001522965A patent/JP2003509350A/en active Pending
- 2000-09-11 CA CA002383570A patent/CA2383570C/en not_active Expired - Fee Related
- 2000-09-11 EP EP00960062A patent/EP1212091B1/en not_active Expired - Lifetime
- 2000-09-11 US US09/658,813 patent/US6503955B1/en not_active Expired - Lifetime
- 2000-09-11 MX MXPA02002607A patent/MXPA02002607A/en active IP Right Grant
- 2000-09-11 TR TR2002/00616T patent/TR200200616T2/en unknown
- 2000-09-11 AT AT00960062T patent/ATE355082T1/en not_active IP Right Cessation
- 2000-09-11 AU AU71282/00A patent/AU770516B2/en not_active Ceased
- 2000-09-11 WO PCT/US2000/024732 patent/WO2001019329A2/en active IP Right Grant
- 2000-09-11 ES ES00960062T patent/ES2282134T3/en not_active Expired - Lifetime
- 2000-09-11 CN CN00812639A patent/CN1373674A/en active Pending
- 2000-09-11 DE DE60033671T patent/DE60033671T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU7128200A (en) | 2001-04-17 |
EP1212091A2 (en) | 2002-06-12 |
JP2003509350A (en) | 2003-03-11 |
US6503955B1 (en) | 2003-01-07 |
ES2282134T3 (en) | 2007-10-16 |
CA2383570C (en) | 2008-08-12 |
WO2001019329A3 (en) | 2001-08-02 |
AU770516B2 (en) | 2004-02-26 |
DE60033671D1 (en) | 2007-04-12 |
MXPA02002607A (en) | 2002-07-30 |
EP1212091B1 (en) | 2007-02-28 |
CN1373674A (en) | 2002-10-09 |
ATE355082T1 (en) | 2006-03-15 |
DE60033671T2 (en) | 2007-12-06 |
TR200200616T2 (en) | 2002-06-21 |
WO2001019329A2 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2383570A1 (en) | Pourable liquid vehicles | |
GR3024043T3 (en) | Antifouling coating composition. | |
WO2004028489A3 (en) | Lipstick comprising a sequenced polymer | |
CA2167971A1 (en) | Solid acid cleaning block and method of manufacture | |
ID22477A (en) | PREVENTION OF COLOR CHANGE IN THE COMPOSITION OF THE COATING CONTAINING PIRITIONA | |
AU5378199A (en) | Hard surface cleaning and disinfecting compositions | |
EP0638636A3 (en) | Hard surface detergent compositions. | |
DE69728594D1 (en) | Chromium-free composition for the treatment of metal surfaces | |
CA2417421A1 (en) | Water-soluble or water-swellable, associatively thickening copolymers containing sulfo groups, method for producing the same and use thereof | |
ATE433280T1 (en) | BIOSTATIC COATINGS TO REDUCE AND PREVENT BACTERIAL ATTACHMENTS | |
CA2204626A1 (en) | Hydrocarbyl containing coatings, compositions and methods of use | |
BR9306962A (en) | Hard surface cleaning composition | |
CA2454516A1 (en) | Method of cleaning floors | |
AU1973900A (en) | Fuel additive and fuel composition containing the same | |
HUP0200737A2 (en) | Multiple component hard surface cleaning composition and container containing thereof | |
ZA979897B (en) | Improvements in or relating to organic compositions. | |
AU3802295A (en) | Sea water-erodible antifouling paint composition | |
AU1915399A (en) | Cs-1 peptidomimetics, compositions and methods of using the same | |
AU3999599A (en) | Polyolefin compositions having variable toughness and/or hardness | |
CA2422678A1 (en) | Compositions and methods for treating surfaces | |
EP0659848A3 (en) | Coating composition and antifouling paint. | |
GB2304115B (en) | Pine oil hard surface cleaning compositions | |
ZA977028B (en) | Increasing the self-polishing properties of anti-fouling paints. | |
AU4488297A (en) | Detergent composition or component | |
AU3495299A (en) | Cleaning chemical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20160912 |